Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP434578.RACaF3KRlXWad53EqDteJ9mJm54cN-nYLbblS2ixxrzXk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP434578.RACaF3KRlXWad53EqDteJ9mJm54cN-nYLbblS2ixxrzXk130_assertion type Assertion NP434578.RACaF3KRlXWad53EqDteJ9mJm54cN-nYLbblS2ixxrzXk130_head.
- NP434578.RACaF3KRlXWad53EqDteJ9mJm54cN-nYLbblS2ixxrzXk130_assertion wasGeneratedBy ECO_0000203 NP434578.RACaF3KRlXWad53EqDteJ9mJm54cN-nYLbblS2ixxrzXk130_provenance.
- NP434578.RACaF3KRlXWad53EqDteJ9mJm54cN-nYLbblS2ixxrzXk130_assertion wasDerivedFrom befree-20150227 NP434578.RACaF3KRlXWad53EqDteJ9mJm54cN-nYLbblS2ixxrzXk130_provenance.
- NP434578.RACaF3KRlXWad53EqDteJ9mJm54cN-nYLbblS2ixxrzXk130_assertion SIO_000772 17620329 NP434578.RACaF3KRlXWad53EqDteJ9mJm54cN-nYLbblS2ixxrzXk130_provenance.
- NP434578.RACaF3KRlXWad53EqDteJ9mJm54cN-nYLbblS2ixxrzXk130_assertion evidence source_evidence_literature NP434578.RACaF3KRlXWad53EqDteJ9mJm54cN-nYLbblS2ixxrzXk130_provenance.
- NP434578.RACaF3KRlXWad53EqDteJ9mJm54cN-nYLbblS2ixxrzXk130_assertion description "[Quantitative analysis of NMDAR2B promoter methylation showed 61% (17/28) hypermethylation in primary gastric tumors versus 5% (1/20) in normal gastric tissues from nongastric cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP434578.RACaF3KRlXWad53EqDteJ9mJm54cN-nYLbblS2ixxrzXk130_provenance.